Kay-Lambkin F - Search Results

1

Smoking cessation and depression: current knowledge and future directions.

Wilhelm K, Wedgwood L, Niven H, Kay-Lambkin F. Wilhelm K, et al. Drug Alcohol Rev. 2006 Jan;25(1):97-107. doi: 10.1080/09595230500459560. Drug Alcohol Rev. 2006. PMID: 16492582 Review.

2

Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention.

Baker A, Ivers RG, Bowman J, Butler T, Kay-Lambkin FJ, Wye P, Walsh RA, Pulver LJ, Richmond R, Belcher J, Wilhelm K, Wodak A. Baker A, et al. Drug Alcohol Rev. 2006 Jan;25(1):85-96. doi: 10.1080/09595230500459552. Drug Alcohol Rev. 2006. PMID: 16492581 Review.

3

Feasibility and outcomes of an innovative cognitive-behavioural skill training programme for co-occurring disorders in the youth alcohol and other drug (AOD) sector.

Hides L, Elkins K, Catania LS, Mathias S, Kay-Lambkin F, Lubman DI. Hides L, et al. Drug Alcohol Rev. 2007 Sep;26(5):517-23. doi: 10.1080/09595230701499134. Drug Alcohol Rev. 2007. PMID: 17701515

4

Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.

Kay-Lambkin FJ. Kay-Lambkin FJ. Drug Alcohol Rev. 2008 May;27(3):318-25. doi: 10.1080/09595230801914768. Drug Alcohol Rev. 2008. PMID: 18368614 Review.

5

Stepping through treatment: reflections on an adaptive treatment strategy among methamphetamine users with depression.

Kay-Lambkin FJ, Baker AL, McKetin R, Lee N. Kay-Lambkin FJ, et al. Drug Alcohol Rev. 2010 Sep;29(5):475-82. doi: 10.1111/j.1465-3362.2010.00203.x. Drug Alcohol Rev. 2010. PMID: 20887570

6

Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment.

Kelly PJ, Baker AL, Deane FP, Kay-Lambkin FJ, Bonevski B, Tregarthen J. Kelly PJ, et al. Drug Alcohol Rev. 2012 Jul;31(5):638-44. doi: 10.1111/j.1465-3362.2012.00465.x. Epub 2012 May 30. Drug Alcohol Rev. 2012. PMID: 22642401

7

Treatments for co-occurring depression and substance use in young people: a systematic review.

Deady M, Teesson M, Kay-Lambkin FJ. Deady M, et al. Curr Drug Abuse Rev. 2014;7(1):3-17. doi: 10.2174/1874473707666141015220608. Curr Drug Abuse Rev. 2014. PMID: 25323123 Review.

8

The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems.

Kay-Lambkin FJ, Baker AL, Lewin TJ. Kay-Lambkin FJ, et al. Drug Alcohol Rev. 2004 Dec;23(4):407-23. doi: 10.1080/09595230412331324536. Drug Alcohol Rev. 2004. PMID: 15763746 Review.

9

Dissemination of a computer-based psychological treatment in a drug and alcohol clinical service: an observational study.

Kay-Lambkin FJ, Simpson AL, Bowman J, Childs S. Kay-Lambkin FJ, et al. Addict Sci Clin Pract. 2014 Aug 9;9(1):15. doi: 10.1186/1940-0640-9-15. Addict Sci Clin Pract. 2014. PMID: 25106668 Free PMC article.

10

Developing a roadmap for the translation of e-mental health services for depression.

Batterham PJ, Sunderland M, Calear AL, Davey CG, Christensen H, Teesson M, Kay-Lambkin F, Andrews G, Mitchell PB, Herrman H, Butow PN, Krouskos D. Batterham PJ, et al. Aust N Z J Psychiatry. 2015 Sep;49(9):776-84. doi: 10.1177/0004867415582054. Epub 2015 Apr 23. Aust N Z J Psychiatry. 2015. PMID: 25907269 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters